Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
Go back to Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)| (NYSE: SER) | Delayed: 2.01 -0.08 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $ | |||
| Open | $2.08 | 52 Week Low | $ | |||
| Day High | $2.20 | P/E | N/A | |||
| Day Low | $2.00 | EPS | $ | |||
| Volume | 1,018,011 | |||||
